Inovio Pharmaceuticals (INO) SEC Filings & 10K Form

$1.96 +0.01 (+0.51%)

Closing price 04:00 PM Eastern

Extended Trading

$1.96 0.00 (-0.26%)

As of 07:49 PM Eastern

Compare

Recent Inovio Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
05/22/2025 4:15 PM	Inovio Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/30/2025 10:24 AM	Inovio Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)	Form SCHEDULE 13G
04/07/2025 3:08 PM	Inovio Pharmaceuticals (Filer)	Form DEF 14A
04/07/2025 3:17 PM	Inovio Pharmaceuticals (Filer)	Form ARS
03/18/2025 3:08 PM	Inovio Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/28/2025 5:05 PM	Inovio Pharmaceuticals (Issuer) Weiner David B. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/28/2025 5:05 PM	Inovio Pharmaceuticals (Issuer) KIES PETER (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/28/2025 5:05 PM	Inovio Pharmaceuticals (Issuer) Shea Jacqueline Elizabeth (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/28/2025 5:05 PM	Inovio Pharmaceuticals (Issuer) Sumner Michael John (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/28/2025 5:06 PM	Humeau Laurent (Reporting) Inovio Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/30/2025 8:58 PM	Inovio Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)	Form SCHEDULE 13G/A
12/23/2024 7:08 PM	Inovio Pharmaceuticals (Subject) Stonepine Capital Management, LLC (Filed by)	Form SCHEDULE 13G
12/18/2024 6:01 PM	Inovio Pharmaceuticals (Issuer) Sumner Michael John (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/16/2024 7:25 AM	Inovio Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/12/2024 3:58 PM	Inovio Pharmaceuticals (Filer)	Form 424B5
10/22/2024 5:06 PM	BlackRock, Inc. (Filed by) Inovio Pharmaceuticals (Subject)	Form SC 13G
08/13/2024 5:22 AM	Inovio Pharmaceuticals (Filer)	Form 424B5
08/13/2024 5:06 AM	Inovio Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/08/2024 4:00 PM	Inovio Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies

SEC Filings Tools

This page (NASDAQ:INO) was last updated on 6/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inovio Pharmaceuticals (INO) SEC Filings & 10K Form

Recent Inovio Pharmaceuticals SEC Filings

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inovio Pharmaceuticals (INO) SEC Filings & 10K Form

Recent Inovio Pharmaceuticals SEC Filings

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools